Investment bank · Netherlands

Van Lanschot Kempen

Deals
1
Latest
Feb 2026
Compare

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deal size
Custom range

1 of 1 deals

Deals Van Lanschot Kempen advised on, most recent first
Advisers
Feb 2026 Agomab Therapeutics NV ––IPOBookrunnerAnnounced200.0Biotech+2 J.P. Morgan (lead manager)Morgan Stanley (lead manager)Leerink Partners (lead manager)Goodwin (issuer)Baker McKenzie (issuer)Davis Polk (lead manager)Clifford Chance (lead manager) Agomab Therapeutics NV IPO

Offices and contact

Contact

From the firm's own website.

Suggest a correction

A missing deal, a wrong role or an office to add. A link to a public source helps.